• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Stage-specific incidence rates and trends of prostate cancer by age, race, and ethnicity, United States, 2004-2014.2004-2014 年美国按年龄、种族和族裔划分的前列腺癌特定阶段发病率和趋势。
Ann Epidemiol. 2018 May;28(5):328-330. doi: 10.1016/j.annepidem.2018.03.001. Epub 2018 Mar 6.
2
Rates and trends in stage-specific prostate cancer incidence by age and race/ethnicity, 2000-2017.2000-2017 年按年龄和种族/族裔划分的特定阶段前列腺癌发病率的比率和趋势。
Prostate. 2021 Oct;81(14):1071-1077. doi: 10.1002/pros.24204. Epub 2021 Jul 28.
3
Trends in Prostate Cancer Incidence and Mortality Rates.前列腺癌发病率和死亡率的趋势
JAMA Netw Open. 2025 Jan 2;8(1):e2456825. doi: 10.1001/jamanetworkopen.2024.56825.
4
Changing Incidence of Metastatic Prostate Cancer by Race and Age, 1988-2015.1988-2015 年种族和年龄对转移性前列腺癌发病率的影响变化。
Eur Urol Focus. 2019 Nov;5(6):1014-1021. doi: 10.1016/j.euf.2018.04.016. Epub 2018 May 4.
5
Prostate cancer incidence rates, trends, and treatment related to prostate-specific antigen screening recommendations in the United States.美国前列腺癌发病率、趋势以及与前列腺特异性抗原筛查建议相关的治疗方法。
Cancer Epidemiol. 2024 Dec;93:102700. doi: 10.1016/j.canep.2024.102700. Epub 2024 Nov 9.
6
Examining the incidence of human papillomavirus-associated head and neck cancers by race and ethnicity in the U.S., 1995-2005.检测美国 1995-2005 年种族和民族之间人乳头瘤病毒相关性头颈部癌症的发病率。
PLoS One. 2012;7(3):e32657. doi: 10.1371/journal.pone.0032657. Epub 2012 Mar 20.
7
An Up-to-date Assessment of US Prostate Cancer Incidence Rates by Stage and Race: A Novel Approach Combining Multiple Imputation with Age and Delay Adjustment.基于年龄和延迟调整的多项插补法对美国按阶段和种族划分的前列腺癌发病率的最新评估:一种新方法。
Eur Urol. 2021 Jan;79(1):33-41. doi: 10.1016/j.eururo.2020.09.041. Epub 2020 Oct 20.
8
Racial and ethnic disparities in gallbladder cancer: A two-decade analysis of incidence and mortality rates in the US.胆囊癌的种族和民族差异:美国二十年来发病率和死亡率的分析。
Cancer Med. 2024 Jul;13(13):e7457. doi: 10.1002/cam4.7457.
9
Variations in Age-Adjusted Prostate Cancer Incidence Rates by Race and Ethnicity After Changes in Prostate-Specific Antigen Screening Recommendation.种族和民族在前列腺特异性抗原筛查建议改变后,年龄调整前列腺癌发病率的变化。
JAMA Netw Open. 2022 Nov 1;5(11):e2240657. doi: 10.1001/jamanetworkopen.2022.40657.
10
Surveillance, Epidemiology, and End Results Data Show Increasing Rates of Distant-Stage Breast Cancer at Presentation in U.S. Women.监测、流行病学和最终结果数据显示,美国女性就诊时远处期乳腺癌的发病率在上升。
Radiology. 2024 Dec;313(3):e241397. doi: 10.1148/radiol.241397.

引用本文的文献

1
Prostate cancer screening in the Middle East and North Africa: a cross-sectional study on current practices.中东和北非地区的前列腺癌筛查:当前实践的横断面研究
JNCI Cancer Spectr. 2025 Mar 3;9(2). doi: 10.1093/jncics/pkaf019.
2
Association between surgery treatment delays and survival outcomes in patients with esophageal cancer in Hebei, China.中国河北食管癌患者手术治疗延迟与生存结局的关联
Front Oncol. 2024 Oct 28;14:1463517. doi: 10.3389/fonc.2024.1463517. eCollection 2024.
3
DNA methylation markers for risk of metastasis in a cohort of men with localized prostate cancer.用于定位性前列腺癌男性患者转移风险的 DNA 甲基化标志物的研究队列。
Epigenetics. 2024 Dec;19(1):2308920. doi: 10.1080/15592294.2024.2308920. Epub 2024 Mar 25.
4
Defining aggressive prostate cancer: a geospatial perspective.定义侵袭性前列腺癌:一种地理空间视角。
BMC Cancer. 2023 Aug 14;23(1):754. doi: 10.1186/s12885-023-11281-8.
5
Trends in prostate cancer incidence among Black men in the Caribbean and the United States.加勒比海地区和美国黑人前列腺癌发病率趋势。
Prostate. 2023 Sep;83(12):1207-1216. doi: 10.1002/pros.24580. Epub 2023 May 27.
6
The presence of lymph node metastases and time to castration resistance predict the therapeutic effect of enzalutamide for castration-resistant prostate cancer.淋巴结转移的存在和去势抵抗时间预测恩杂鲁胺治疗去势抵抗性前列腺癌的疗效。
Int J Clin Oncol. 2023 Mar;28(3):427-435. doi: 10.1007/s10147-022-02288-5. Epub 2022 Dec 29.
7
A Historical Misconception in Clinical Trials of Drugs for Cancer-Age Grouping.癌症药物临床试验中的一个历史误解——年龄分组
J Pers Med. 2022 Dec 2;12(12):1998. doi: 10.3390/jpm12121998.
8
Increasing aggressive prostate cancer.侵袭性前列腺癌增多。
Can J Urol. 2022 Dec;29(6):11384-11390.
9
Integrated analysis to identify the AC005154.6/hsa-miR-29c-3p/CCNL2 axis as a novel prognostic biomarker associated with immune infiltration in prostate cancer.综合分析以确定AC005154.6/hsa-miR-29c-3p/CCNL2轴作为一种与前列腺癌免疫浸润相关的新型预后生物标志物。
Cancer Cell Int. 2022 Nov 11;22(1):346. doi: 10.1186/s12935-022-02779-5.
10
Exposure to statins post localized prostate cancer diagnosis and risk of metastasis among men who did not receive curative prostate cancer treatment.局限性前列腺癌诊断后接触他汀类药物与未接受根治性前列腺癌治疗的男性发生转移的风险。
Cancer Rep (Hoboken). 2023 Mar;6(3):e1749. doi: 10.1002/cnr2.1749. Epub 2022 Nov 8.

本文引用的文献

1
Past, Current, and Future Incidence Rates and Burden of Metastatic Prostate Cancer in the United States.美国转移性前列腺癌的过去、现在和未来发病率及负担。
Eur Urol Focus. 2018 Jan;4(1):121-127. doi: 10.1016/j.euf.2017.10.014. Epub 2017 Nov 20.
2
Contemporary Trends in the Incidence of Metastatic Prostate Cancer Among US Men: Results from Nationwide Analyses.当代美国男性转移性前列腺癌发病率的趋势:来自全国性分析的结果。
Eur Urol Focus. 2019 Jan;5(1):77-80. doi: 10.1016/j.euf.2017.04.012. Epub 2017 May 12.
3
Increase in Prostate Cancer Distant Metastases at Diagnosis in the United States.美国前列腺癌诊断时远处转移的增加。
JAMA Oncol. 2017 May 1;3(5):705-707. doi: 10.1001/jamaoncol.2016.5465.
4
Prostate Cancer Incidence Rates 2 Years After the US Preventive Services Task Force Recommendations Against Screening.美国预防服务工作组建议停止筛查后两年的前列腺癌发病率
JAMA Oncol. 2016 Dec 1;2(12):1657-1660. doi: 10.1001/jamaoncol.2016.2667.
5
Trends in United States Prostate Cancer Incidence Rates by Age and Stage, 1995-2012.1995 - 2012年美国前列腺癌发病率按年龄和阶段的趋势
Cancer Epidemiol Biomarkers Prev. 2016 Feb;25(2):259-63. doi: 10.1158/1055-9965.EPI-15-0723. Epub 2015 Dec 8.
6
Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations.与 USPSTF 筛查建议相关的前列腺癌发病率和 PSA 检测模式。
JAMA. 2015 Nov 17;314(19):2054-61. doi: 10.1001/jama.2015.14905.
7
Decrease in Prostate Cancer Testing Following the US Preventive Services Task Force (USPSTF) Recommendations.美国预防服务工作组(USPSTF)发布建议后前列腺癌检测率下降。
J Am Board Fam Med. 2015 Jul-Aug;28(4):491-3. doi: 10.3122/jabfm.2015.04.150062.
8
Early detection of prostate cancer: AUA Guideline.早期前列腺癌检测:AUA 指南。
J Urol. 2013 Aug;190(2):419-26. doi: 10.1016/j.juro.2013.04.119. Epub 2013 May 6.
9
Cancer screening in the United States, 2013: a review of current American Cancer Society guidelines, current issues in cancer screening, and new guidance on cervical cancer screening and lung cancer screening.美国 2013 年癌症筛查:对当前美国癌症协会指南、癌症筛查当前问题以及宫颈癌筛查和肺癌筛查新指南的回顾。
CA Cancer J Clin. 2013 Mar-Apr;63(2):88-105. doi: 10.3322/caac.21174. Epub 2013 Feb 1.
10
Declines in prostate cancer incidence after changes in screening recommendations.筛查建议改变后前列腺癌发病率的下降。
Arch Intern Med. 2012 Sep 10;172(16):1267-8. doi: 10.1001/archinternmed.2012.2768.

2004-2014 年美国按年龄、种族和族裔划分的前列腺癌特定阶段发病率和趋势。

Stage-specific incidence rates and trends of prostate cancer by age, race, and ethnicity, United States, 2004-2014.

机构信息

Epidemiology and Applied Research Branch, Division of Cancer and Prevention, National Center for Chronic Disease Prevention and Health Promotion, CDC, Atlanta, GA.

Epidemiology and Applied Research Branch, Division of Cancer and Prevention, National Center for Chronic Disease Prevention and Health Promotion, CDC, Atlanta, GA; Epidemic Intelligence Service, CDC, Atlanta, GA.

出版信息

Ann Epidemiol. 2018 May;28(5):328-330. doi: 10.1016/j.annepidem.2018.03.001. Epub 2018 Mar 6.

DOI:10.1016/j.annepidem.2018.03.001
PMID:29678312
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6080305/
Abstract

PURPOSE

Current literature shows different findings on the contemporary trends of distant-stage prostate cancer incidence, in part, due to low study population coverage and wide age groupings. This study aimed to examine the stage-specific incidence rates and trends of prostate cancer by age (5-year grouping), race, and ethnicity using nationwide cancer registry data.

METHODS

Data on prostate cancer cases came from the 2004-2014 United States Cancer Statistics data set. We calculated stage-specific incidence and 95% confidence intervals by age (5-year age grouping), race, and ethnicity. To measure the changes in rates over time, we calculated annual percentage change (APC).

RESULTS

We identified 2,137,054 incident prostate cancers diagnosed during 2004-2014, with an age-adjusted incidence rate of 453.8 per 100,000. Distant-stage prostate cancer incidence significantly decreased during 2004-2010 (APC = -1.2) and increased during 2010-2014 (APC = 3.3). Significant increases in distant prostate cancer incidence also occurred in men aged older than or equal to 50 years except men aged 65-74 and older than or equal to 85 years, in men with white race (APC = 3.9), and non-Hispanic ethnicity (APC = 3.5).

CONCLUSIONS

Using data representing over 99% of U.S. population, we found that incidence rates of distant-stage prostate cancer significantly increased during 2010-2014 among men in certain ages, in white, and with non-Hispanic ethnicity.

摘要

目的

目前的文献显示,由于研究人群覆盖范围低和年龄分组广泛,当代前列腺癌远处转移阶段发病率的趋势存在不同的结果。本研究旨在使用全国癌症登记数据,通过年龄(5 年分组)、种族和族裔检查前列腺癌的特定分期发病率和趋势。

方法

前列腺癌病例数据来自 2004-2014 年美国癌症统计数据。我们按年龄(5 年年龄分组)、种族和族裔计算了特定分期的发病率和 95%置信区间。为了衡量随时间变化的发病率变化,我们计算了年百分比变化(APC)。

结果

我们确定了 2137054 例在 2004-2014 年间诊断的前列腺癌病例,年龄调整后的发病率为 453.8/100000。2004-2010 年间远处转移前列腺癌的发病率显著下降(APC=-1.2),2010-2014 年间发病率增加(APC=3.3)。除了年龄在 65-74 岁及以上和 85 岁及以上的男性外,年龄在 50 岁及以上的男性、白人男性(APC=3.9)和非西班牙裔男性(APC=3.5)的远处前列腺癌发病率也显著增加。

结论

使用代表超过 99%的美国人口的数据,我们发现 2010-2014 年间,在某些年龄、白人、非西班牙裔人群中,远处转移阶段前列腺癌的发病率显著增加。